Aldeyra Therapeutics Announces Clinical Development Plan for Resubmission of New Drug Application for Reproxalap in Dry Eye Disease
Stock Information for Aldeyra Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.